Call for Abstract
Scientific Program
International Conference on Neurological disorder and Neuroimmunology, will be organized around the theme “
Neuroimmunology 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Neuroimmunology 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Track 2: Stroke
Stroke is the sudden brain attack. It happens when the blood flow to the brain is blocked or rupturing of blood vessels. Ischemic stroke occurs when an artery to the brain is blocked. The brain depends on its arteries to bring fresh blood from the heart and lungs. The blood carries oxygen and nutrients to the brain, and takes away carbon dioxide and cellular waste. If an artery is blocked, the brain cells cannot make enough energy and will eventually stop working. If the artery remains blocked for more than a minute, the apoptosis of brain cells will occur and also structural integrity of brain tissue and blood vessel will be lost. The most common problem is narrowing of the arteries in the neck or head. This is most often caused by atherosclerosis, or gradual cholesterol deposition. It is mostly observed in women and children.
- Track 1-1Transient ischemic stroke attack
- Track 1-2Hemorrhagic strokes
- Track 1-3Pediatric strokes
- Track 1-4Signs and symptoms of stroke
- Track 1-5Pathophysiology of stroke
- Track 1-6Advanced treatment for strokes
- Track 1-7Epidemiology of stroke
Track 1: Cardiovascular Diseases
Cardiology is the division of medicine concerned with the illness of heart and the blood vessels, which also involves diagnosis and treatment of the diseases. Heart diseases are said to be cardiovascular Disease which is a major cause of disability and premature death throughout the world. Acute coronary events (heart attacks) and cerebrovascular events (strokes) occur suddenly, and are often fatal before medical care can be given. Symptoms include shortness of breath, chest pain, and extreme fatigue. Cardiology conferences promote awareness against risk factor modification about the heart diseases. It reduces clinical events and premature death in people with cardiovascular disease risk. Cardiovascular disease is treatable with initial treatment primarily focused on diet and lifestyle interventions.
- Track 2-1pediatric cardiovascular pharmacology
- Track 2-2Ischemic heart disease
- Track 2-3Hypertensive heart disease
- Track 2-4Pulmonary heart disease
- Track 2-5Percardial disease
- Track 2-6Cardiac dysrhythmias
- Track 2-7Myocardial infraction
- Track 2-8Congestive heart failure
- Track 2-9Cardiomyopathy
Track 3: Arrhythmia
Cardiac arrhythmia means irregular heart beat or heart rhythm where muscles of heart contract in a coordinated fashion to insure that blood is been efficiently pumped into the arteries and the extra heart beat are due to premature atrial contraction and premature ventricular contraction. The electrical impulses are responsible for arrhythmia condition. The Wolff–Parkinson–White syndrome (WPW) is one of the disorders of electrical system of the heart which are commonly referred to as pre-excitation syndromes which is caused by the presence of an abnormal accessory electrical conduction pathways between the atria and ventricles. Treatments may include physical maneuvers, medications, electrical conversion, electro-or cryo-cautery. Arrhythmia can be managed from various ways such as SCA risk assessments, non-invasive techniques, clinical electrophysiology are some clinical techniques and epidemiology of cardiac arrhythmia.
- Track 3-1Atrial fibrillation
- Track 3-2Junctional arrhythmias
- Track 3-3Ventricular arrhythmias
- Track 3-4Sudden arrhythmic death syndrome
- Track 3-5Wolff-parkinson-white syndrome
- Track 3-6Antiarrhythmic and anticoagulants drugs
Track 4: Peripheral artery diseases
Peripheral artery disease (PAD) is a narrowing of the peripheral arteries in legs, stomach, arms, and head by forming plaque inside the arteries. Mostly the arteries of legs get affected. The blocked blood flow to the legs can cause pain and numbness. It can also raise risk of getting an infection resulting in tissue death (gangrene). PAD increases your risk of coronary heart disease, heart attack, stroke, and transient ischemic attack. PAD can be treated by lifestyle changes, medicines and revascularization.
- Track 4-1Intermittent claudication
- Track 4-2Critical limb ischemia
- Track 4-3Symptoms and cause of PAD
- Track 4-4Preliminary diagnostic procedure
- Track 4-5Revascularization
Track 5: Congenital heart diseases
Congenital heart defects are problems with the heart's structure that are present at birth. Congenital heart defects change the normal flow of blood through the heart. This defect develops in the womb, before the baby is born. During pregnancy the mother having some infections such as rubella or poorly controlled type 1 or type 2 diabetes can cause CHD. Some genetic disorders such as Down syndrome or any chromosome defects leads to CHD. Congenital heart disease affects 8 out of every 1,000 newborns. Each year, more than 35,000 babies in the United States are born with congenital heart defects
- Track 5-1Cyanotic and non-cyanotic heart effects
- Track 5-2Genetics of CHD
- Track 5-3Stages of Congenital heart diseases
- Track 5-4The impact of Congenital heart defects
- Track 5-5Nutritional issues of CHD
- Track 5-6Statistical report on infant mortality
Track 6: Cardiac surgery
Cardiac surgery is the field of medicine involved in surgical treatment of diseases affecting organs inside the thorax generally treatment of conditions of the heart and lungs by the cardiac surgeons. Coronary artery bypass grafting (CABG) is done to restore normal blood flow to heart muscle. Cardiac cognitive impairment, Cardiac valve disease, Atrial sepal defect repair, Ventricular sepal defect repair are done for cardiac surgery. Pediatric heart surgeons treat complex congenital heart defects in newborns, children, and adolescents. During open heart surgery the heart-lung bypass machine takes over the function of the heart and lungs to provide oxygenated blood to the body. Post-surgical procedure helps the patients to heal the surgical wound and also from infections.
- Track 6-1Cardiac cognitive impairment
- Track 6-2Pediatric cardiovascular surgery
- Track 6-3Atrial sepal defect repair
- Track 6-4Thoraic endovascular aortic repair
- Track 6-5Post-infraction ventricular septal defect repair
- Track 6-6Heart valve repair and replacement surgery
- Track 6-7Cardiomyoplasty
- Track 6-8Artificial heart valve surgery
- Track 6-9Angioplasty
- Track 6-10Transmyocardial revascularization
- Track 6-11Minimally invasive/robotic heart surgery
- Track 6-12Carotid endarterectomy
- Track 6-13Coronary artery bypass surgery
- Track 6-14Risk of cardiac surgery
- Track 6-15Cardiac surgeons
Track 7: Pulmonary disorder
Pulmonary disease is a term that encompasses pathological conditions affecting the organs and tissues of the lungs and the respiratory tract. It includes the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity. The lung disease may cause inflammation, restrictive or infections to the respective tissues. Major cause of pulmonary disease is due to smoking, occupational exposures and also the genetic makeup of an individual. Pulmonary diseases may also impact newborns, such as pulmonary hyperplasia and Infant respiratory distress syndrome.
- Track 7-1Interstitial lung disease
- Track 7-2Chronic respiratory diseases
- Track 7-3Pleural cavity diseases
- Track 7-4Pulmonary vascular disease
- Track 7-5pulmonary disorder in infants
- Track 7-6Bronchoscopy
- Track 7-7global status report on Pulmonary disorder
Track 8: Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes it hard to breathe. It develops slowly. Symptoms often worsen over time and can limit your ability to do routine activities. Severe COPD may prevent you from doing even basic activities like walking, cooking etc. Alpha1-antitrypsin deficiency (AATD) is a relatively common genetic condition for Chronic obstructive pulmonary disease. People with AATD are predisposed to obstructive pulmonary disease and liver disease. Adult stem cell therapy is a new alternative treatment to help manage the complications of COPD. This stem cell heal the plagued cell with disease
- Track 8-1Emphysema
- Track 8-2Genetic Factors in COPD
- Track 8-3Oxygen Therapy
- Track 8-4Pulmonary Rehabilitation
- Track 8-5Lifestyle factors for COPD
- Track 8-6Research in COPD
- Track 8-7WHO Global Alliance against CRD
Track 9: Lung Cancer
Lung cancer is results of unconditional cell growth in tissues of the lungs by the process of metastasis. Large numbers of people are suffering from lung carcinoma due to long time smoking and also second-hand smoke. The abnormal activation of genes in normal cell leads to carcinoma. Molecular oncology involve in finding out genes that are responsible for the development of cancer. Cancer cells differ from normal cells in size, structure, function, and growth rate. In cancer cells growth rate is faster. Common treatments include palliative care, surgery, chemotherapy, and radiation therapy. Bevacizumab is an anti- angiogenic monoclonal antibody in trials for advanced non- small cell lung cancer treatment.
- Track 9-1bronchogenic carcinomas
- Track 9-2Epigenetic of lung cancer
- Track 9-3Pathogenesis of carcinoma
- Track 9-4Lung Cancer: Complications
- Track 9-5lung biopsy
- Track 9-6Chemotherapy
- Track 9-7clinical trials
Track 10: Pulmonary Hypertension
Pulmonary hypertension (PH) is the increase of blood pressure in the pulmonary artery, vein, or capillaries due to the narrowing of arteries and capillaries to and within the lungs, which leads to shortness of breath, dizziness, fainting, leg swelling and other symptoms. Symptoms of pulmonary hypertension do not usually occur until the condition has progressed. The first symptom of pulmonary hypertension is usually shortness of breath with everyday activities, such as climbing stairs. Fatigue, dizziness, and fainting spells also can be symptoms. The molecular mechanism of pulmonary arterial hypertension (PAH) is not known clearly. The endothelial dysfunction decreases the synthesis of endothelium-derived vasodilators such as nitric oxide and prostacyclin. Diagnosis of the severe heart condition includes mainly Echocardiography or as per the signs and symptoms of the particular disease condition. Treatment for pulmonary hypertension will not cure the condition but improve the quality of life.
- Track 10-1Pulmonary arterial hypertension
- Track 10-2Pulmonary hypertension owing to lung and heart disease
- Track 10-3Hypoxic pulmonary vasoconstriction
- Track 10-4life expectancy for pulmonary hypertension
Track 11: Diagnosis of pulmonary disorder
Diagnosis is the act or process of identifying the nature and cause of a disease or injury through the systematic analysis of patient signs and symptoms. The physicians will do the physical examination of the patients followed by laboratory test such as Chest x-ray, pulmonary function tests, arterial blood gases, lung scan, Electrocardiogram (ECG), spirometry and Bronchoscopy. Angiography is an x-ray based technique used to image the veins, arteries, blood vessel. It is a part of projection radiography. The angiography devices market is expected to reach $27.7 billion by the year 2019
- Track 11-1Breathing Strategies
- Track 11-2Mechanical Ventilation
- Track 11-3Angiography
- Track 11-4Ultrasonography
- Track 11-5Smoking Cessation Clinic & Laser Acupuncture
- Track 11-6Positron emission tomography
- Track 11-7Spirometry
- Track 11-8BronchoscopyÂ
- Track 11-9Thoracentesis
Track 12: Chest Imaging
Chest Imaging interprets cross sectional imaging studies of the heart and pulmonary system using Computed Tomography (CT or "CAT" scans) and Magnetic Resonance Imaging (MRI) with a volume of more than 2,500 studies each year. CT and MRI are non-invasive imaging modalities, meaning that no catheterization is required. MUSC operates the most up-to-date, cutting edge imaging equipment to ensure optimal diagnostic quality in patient care while also minimizing patient exposure to ionizing radiation. The chest radiograph imaging has some limitations in their use.
- Track 12-1Magnetic Resonance ImagingÂ
- Track 12-2Heart MRI
- Track 12-3Chest radiography
- Track 12-4Tactile imaging
- Track 12-5advanced Digital Chest Radiography
- Track 12-6limitations of chest imaging
Track 13: Echocardiography
Echocardiography is a painless test that uses sound waves to create moving pictures of your heart. The pictures show the size and shape of your heart. They also show how well your heart's chambers and valves are working. It pin point areas of heart muscle that aren't contracting well because of poor blood flow or injury from a previous heart attack. It also detects possible blood clots inside the heart, fluid buildup in the pericardium and problems with the aorta. The American Society of Echocardiography (ASE) is a professional organization made up of physicians, sonographers, nurses, and scientists involved in the field of echocardiography. Echocardiography is performed by cardiac sonographers, cardiac physiologists (UK) or trained doctors in echocardiography. Echocardiography was invented by Milton R. Hejtmancik, MD, from which he was awarded the AMA Billings Gold Medal in 1972.
- Track 13-1Medical Ultrasound/ Ultrasonography
- Track 13-2Stress echocardiography
- Track 13-3Mitral Regurgitation
- Track 13-4Hemodynamics Echocardiography
- Track 13-5Contrast Echocardiography
- Track 13-6Â Doppler echocardiography
- Track 13-7Three-dimensional Echocardiography
- Track 13-8Cardiac catheterization and coronary angiography
- Track 13-9Thrombolytic therapy
- Track 13-10Cardiomyopathies
Track 14: Cardiovascular pharmacology
Cardiovascular pharmacology deals with the medication of cardiac diseases. The Cardiac Drugs are used to treat conditions of the heart or the circulatory or vascular system. Many classes of cardiovascular agents are available to treat the various cardiovascular conditions. In this sub topic we have Sodium, potassium, calcium channel blockers, ACE-inhibitors and Cardiac biomarkers. There are 6 associations and societies and the main association for Cardiac Therapeutic Agents in USA. 50 universities are working on Cardiac Therapeutic Agents. Three new drugs were introduced in 2015. There are many types of cardiovascular drugs in the market that include Cardiac glycosides, anti-coagulants, anti-arrhythmic agents, anti-anginal agents and anti-hypertensive agents.
- Track 14-1pharmacology
- Track 14-2pharmacology
- Track 14-3clinical pharmacology
- Track 14-4Neonatal Cardiovascular Pharmacology
- Track 14-5Acute Care
- Track 14-6Acute Care
- Track 14-7Anti Platelet agents
- Track 14-8Statins
- Track 14-9cardiac therapeutics
Track 15: Pulmonary Therapy
Pulmonary therapy includes the program of exercise and treatment to help patients maintain and lung function. The treatments to help lung diseases are postural drainage, suctioning, and breathing exercises. It is defined by the American Thoracic Society and the European Respiratory Society. Pulmonary therapists are specialists and educators in pulmonology. They are often in charge of initiating and managing life support for people in intensive care units and emergency departments. The NICE clinical guideline on chronic obstructive pulmonary disease states that “pulmonary rehabilitation should be offered to every patient who considers themselves functionally disabled by COPD. Medications are Anti-inflammatory agents (inhaled steroids), Bronchodilators, Long-acting bronchodilators, Beta-2 agonists, Anticholinergic agents, Oral steroids, Antibiotics, Mucolytic agents, Oxygen therapy, or Preventative therapy.
- Track 15-1Lung Surgery
- Track 15-2Nutritional education
- Track 15-3Corticosteroids
- Track 15-4Anti-Asthmatic Drugs
- Track 15-5Â Bronchodilators
Track 16: Heart and lung transplant
A heart transplant or a cardiac transplant is a surgical transplant procedure performed on patients with end-stage heart failure or severe coronary artery disease. Pediatric heart transplantation is important treatment choice in the end stage of heart disease in children. In heart transplantation some post-operative complications are there, those are infections, organ rejection as well as side effects due to immunosuppressive medications. There are selective criteria for potential lung donors due to the needs of the potential recipients, after lung transplantation several pulmonary infection occur especially viral infection by cytomegalovirus and rejection of organ. Cardiothoracic surgery is the field of medicine involved in surgical treatment of organs inside the thorax (the chest). Better supervision of medical complications leads to better long term outcomes.
- Track 16-1congenital and pulmonary hypertension
- Track 16-2Cardiothoracic surgery
- Track 16-3complications and risk in transplant
- Track 16-4Post-operative care
- Track 16-5Statistics of transplant
Track 17: Implantable cardiac devices
The cardiac devices which are implant inside the body will monitor and control the heart rhythms. This devices are programmed to detect abnormal heart rhythms and deliver therapy via programmable anti-tachycardia pacing in addition to low-energy and high-energy shocks. Risk of ICD is that sometimes it leads to infection in the surgical site and failure to deliver therapy when it is needed. The global market for cardiac equipment grew from $49.4 billion in 2013 to $52 billion in 2014.
- Track 17-1Cardiac Angioplasty Devices
- Track 17-2Cardiac Pacemakers
- Track 17-3Implantable Cardioverter DefibrillatorÂ
- Track 17-4Left Ventricular Assist Device
- Track 17-5Left Ventricular Assist Device
- Track 17-6Cardiac Ablation Catheters
- Track 17-7Prosthetic (Artificial) Heart Valves
- Track 17-8Ventricular Assist Devices (VADs)
Track 18: Case reports on cardiac and pulmonary diseases
CVDs are the number 1 cause of death globally. More people die annually from CVDs than from any other cause. In 2012, 17.5 million people died due cardiac vascular disease. More than 3 million died due to COPD’s. 235 million people suffer from asthma, which is common among the children. Cardiac vascular disease and pulmonary disease are very invasive among developing countries than the developed countries. The aim of the WHO Chronic Respiratory Diseases Programme is to support Member States in their efforts to reduce the toll of morbidity, disability and premature mortality related to chronic respiratory diseases, and specifically, asthma and chronic obstructive pulmonary disease.
- Track 18-1Prevalence of Chest infections on adult population
- Track 18-2Epidemiology of Cardiovascular Disease
- Track 18-3Hypertension
- Track 18-4Myocardial infarction
- Track 18-5pediatric heart disease